'Compassionate' permit for Sinopharm shots not retroactive, FDA says

SunStar
File
February 12, 2021
THE Food and Drug Administration (FDA) on Friday, February 12, 2021, said the “compassionate special permit” (CSP) issued for the use of 10,000 doses of Sinopharm vaccine against coronavirus disease 2019 (Covid-19) is for future use and is not retroactive.
The investigation into the unauthorized use of the vaccine by the Presidential Security Group (PSG) is still ongoing, FDA Director General Eric Domingo said in a virtual interview with reporters Friday.
"That's still ongoing. That has nothing to do with the CSP. The CSP is for future use. It's a forward permit," said Domingo.
He said the issuance of the CSP cannot be used to justify the PSG’s unauthorized use of the vaccine in 2020.

Related Keywords

China ,Philippines ,Chinese ,Eric Domingo ,Rodrigo Duterte ,Pfizer ,Astrazeneca ,Presidential Security Group ,Drug Administration ,General Eric Domingo ,Emergency Use Authorization ,President Rodrigo Duterte ,Sunstar Philippines ,Covid 19 Vaccine ,Sinopharm Vaccine ,Psg Vaccination ,சீனா ,பிலிப்பைன்ஸ் ,சீன ,எரிக் டொமிஂகொ ,ஃபைசர் ,ப்ரெஸிடெந்ஶியல் பாதுகாப்பு குழு ,ஜநரல் எரிக் டொமிஂகொ ,அவசரம் பயன்பாடு அங்கீகாரம் ,சன்ஸ்டார் பிலிப்பைன்ஸ் ,பஸ்க் தடுப்பூசி ,